Literature DB >> 10463862

Immune surveillance and antigen conformation determines humoral immune response to the prion protein immunogen.

R Rubenstein1, R J Kascsak, M Papini, R Kascsak, R I Carp, G LaFauci, R Meloen, J Langeveld.   

Abstract

Transmissible spongiform encephalopathies (TSE) are progressive degenerative disorders of the central nervous system. PrP(Sc) is a TSE-specific marker derived from the host-encoded glycoprotein, PrPc. The generation of antibodies to PrP plays an important role in the diagnosis of these diseases. In this study the role of the PrP immunogen and the species being immunized was examined in relation to specific epitopes. Various mammals (mice, hamsters, rabbits and PrP null mice) were immunized with formic acid-treated PrP(Sc) isolated from mice, hamsters and sheep. Both the species being immunized and the source of immunogen played an important role in the antibody response. Response to a limited number of linear epitopes was seen among the various immunized animals. One region in the C-terminal portion of PrP appeared highly immunogenic in all species. Comparison of immunoreactivity and the pepscan-defined linear epitope sites suggests both linear and conformational directed responses in many of the animals. Information on the forces directing immune responses to PrP will lead to a better understanding of host-PrP interactions. It will also assist in the development of new strategies for generating additional tools for immunodiagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463862     DOI: 10.3109/13550289909029481

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  8 in total

1.  Reiterating the epitope specificity of prion-specific mAb 3F4.

Authors:  Richard Kascsak
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

2.  Generation of antibodies against bovine recombinant prion protein in various strains of mice.

Authors:  Olga Andrievskaia; Heather McRae; Cathy Elmgren; Hongsheng Huang; Aru Balachandran; Klaus Nielsen
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Role of CD40 in prion disease and the immune response to recombinant PrP.

Authors:  Richard Rubenstein; Allen Chiu; Binggong Chang; Thomas Wisniewski
Journal:  J Neuroimmunol       Date:  2013-02-16       Impact factor: 3.478

4.  Unaltered prion protein expression in Alzheimer disease patients.

Authors:  Eri Saijo; Stephen W Scheff; Glenn C Telling
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

5.  Assessing transmissible spongiform encephalopathy species barriers with an in vitro prion protein conversion assay.

Authors:  Christopher J Johnson; Christina M Carlson; Aaron R Morawski; Alyson Manthei; Neil R Cashman
Journal:  J Vis Exp       Date:  2015-03-10       Impact factor: 1.355

6.  PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.

Authors:  Mourad Tayebi; Daryl Rhys Jones; William Alexander Taylor; Benjamin Frederick Stileman; Charlotte Chapman; Deming Zhao; Monique David
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

7.  Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity.

Authors:  Sandra McCutcheon; Jan P M Langeveld; Boon Chin Tan; Andrew C Gill; Christopher de Wolf; Stuart Martin; Lorenzo Gonzalez; James Alibhai; A Richard Alejo Blanco; Lauren Campbell; Nora Hunter; E Fiona Houston
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

8.  Influence of Mabs on PrP(Sc) formation using in vitro and cell-free systems.

Authors:  Binggong Chang; Robert Petersen; Thomas Wisniewski; Richard Rubenstein
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.